VeriMombeheneth-20 hamilelikte güvenli mi?
Authoritative cosmetic/toxicology sources treat beheneth compounds as topical surfactants/emulsifiers and list Beheneth‑20 in CIR resources; reproductive/developmental studies on the parent (docosanol/1‑docosanol) show no adverse effects and dermal systemic exposure is reported as negligible, so no reproductive hazard is identified for topical cosmetic use. (CIR ingredient page; ECHA registration summaries; EPA support document on 1‑docosanol). URLs: https://cir-safety.org/ingredient/beheneth-20 , https://echa.europa.eu/registration-dossier/-/registered-dossier/17453/7/9/4 , https://www.epa.gov/sites/default/files/2019-08/documents/support_document_for_proposed_designation_of_1-docosanol.pdf
Pregnancy-safe products containing beheneth-20
Related ingredients
Frequently asked questions
- beheneth-20 hamilelikte güvenli mi?
- Authoritative cosmetic/toxicology sources treat beheneth compounds as topical surfactants/emulsifiers and list Beheneth‑20 in CIR resources; reproductive/developmental studies on the parent (docosanol/1‑docosanol) show no adverse effects and dermal systemic exposure is reported as negligible, so no reproductive hazard is identified for topical cosmetic use. (CIR ingredient page; ECHA registration summaries; EPA support document on 1‑docosanol). URLs: https://cir-safety.org/ingredient/beheneth-20 , https://echa.europa.eu/registration-dossier/-/registered-dossier/17453/7/9/4 , https://www.epa.gov/sites/default/files/2019-08/documents/support_document_for_proposed_designation_of_1-docosanol.pdf
- beheneth-20 emzirirken güvenli mi?
- No evidence of reproductive/developmental hazard or of significant systemic absorption after topical application; regulatory/toxicology summaries for docosanol indicate negligible systemic exposure and state use in pregnancy/breastfeeding is not expected to affect the infant. (ECHA registration summaries; product/labeling summaries referencing low systemic absorption of docosanol). URLs: https://echa.europa.eu/registration-dossier/-/registered-dossier/17453/7/9/4 , https://www.epa.gov/sites/default/files/2019-08/documents/support_document_for_proposed_designation_of_1-docosanol.pdf
- beheneth-20 bebek cildi için güvenli mi?
- Hazard and mechanism: no evidence of developmental/reproductive toxicity specific to infants and no endocrine liability in authoritative dossiers. Exposure: because infant (0–3 yr) skin barrier is immature and surface‑area‑to‑weight ratio is higher, absorption potential is higher than adult; therefore exposure score increased by +1 relative to adults (adult e=0 → infant e=1) although available data still indicate low systemic uptake for docosanol/ethoxylates after dermal use. (ECHA registration summaries; CIR listing; Health Canada NHPID listing). URLs: https://echa.europa.eu/registration-dossier/-/registered-dossier/17453/7/9/4 , https://cir-safety.org/ingredient/beheneth-20 , https://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq?id=16112
- VeriMom beheneth-20 nasıl puanlıyor?
- VeriMom beheneth-20'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte beheneth-20 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.